Seroprevalence of Hepatitis E Virus in an Adult Urban Population from Burundi

Pierre Aubry Departement de Medecine Interne, Centre Hospitalo Universitaire de Kamenge, Laboratoire de Biologie Clinique, Hopital Robert Picque, Abbott Diagnostic, Unite de Recherches sur la Prevention et le Traitement ces Maladies Infectieuses (INSERM), Bujumbura, Burundi

Search for other papers by Pierre Aubry in
Current site
Google Scholar
PubMed
Close
,
Loic Niel Departement de Medecine Interne, Centre Hospitalo Universitaire de Kamenge, Laboratoire de Biologie Clinique, Hopital Robert Picque, Abbott Diagnostic, Unite de Recherches sur la Prevention et le Traitement ces Maladies Infectieuses (INSERM), Bujumbura, Burundi

Search for other papers by Loic Niel in
Current site
Google Scholar
PubMed
Close
,
Theodore Niyongabo Departement de Medecine Interne, Centre Hospitalo Universitaire de Kamenge, Laboratoire de Biologie Clinique, Hopital Robert Picque, Abbott Diagnostic, Unite de Recherches sur la Prevention et le Traitement ces Maladies Infectieuses (INSERM), Bujumbura, Burundi

Search for other papers by Theodore Niyongabo in
Current site
Google Scholar
PubMed
Close
,
Sylvie Kerguelen Departement de Medecine Interne, Centre Hospitalo Universitaire de Kamenge, Laboratoire de Biologie Clinique, Hopital Robert Picque, Abbott Diagnostic, Unite de Recherches sur la Prevention et le Traitement ces Maladies Infectieuses (INSERM), Bujumbura, Burundi

Search for other papers by Sylvie Kerguelen in
Current site
Google Scholar
PubMed
Close
, and
Bernard Larouze Departement de Medecine Interne, Centre Hospitalo Universitaire de Kamenge, Laboratoire de Biologie Clinique, Hopital Robert Picque, Abbott Diagnostic, Unite de Recherches sur la Prevention et le Traitement ces Maladies Infectieuses (INSERM), Bujumbura, Burundi

Search for other papers by Bernard Larouze in
Current site
Google Scholar
PubMed
Close
Restricted access

The prevalence of antibodies to the hepatitis E virus (HEV) was measured in a group of 129 adults from Bujumbura, Burundi, using an ELISA. The prevalence of anti-HEV IgG was 14%, much lower than that of hepatitis A virus (HAV) (97.7%). In addition to the lability of antibodies to HEV, this difference might be explained by the extensive availability of good-quality drinking water in the city. The presence of serologic markers of HBV (77.6%), HCV (27.1%), and human immunodeficiency virus (30.2%) was not associated with that of anti-HEV.

Author Notes

Save